高级检索
当前位置: 首页 > 详情页

Association between Mismatch-repair Genetic variation and the Risk of Multiple Primary Cancers: A Meta-Analysis

文献详情

资源类型:
机构: [1]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510000, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Canc Ctr, Dept VIP Reg, 651 East Dongfeng Rd, Guangzhou 510000, Guangdong, Peoples R China; [3]Second Peoples Hosp Lu An City, Dept Oncol Surg, Lu An 237000, Peoples R China; [4]Guangdong Women & Children Hosp, Dept Gynecol, Guangzhou 510010, Guangdong, Peoples R China; [5]Sun Yat Sen Univ, Canc Ctr, Dept ICU, Guangzhou 510000, Guangdong, Peoples R China; [6]Sun Yat Sen Univ, Canc Ctr, Dept Gastr & Pancreat Surg, Guangzhou 510000, Guangdong, Peoples R China
出处:
ISSN:

关键词: microsatellites instability multiple Primary Cancers risk factor meta-analysis

摘要:
Microsatellites instability (MSI) is a risk factor for multiple primary cancers (MPCs). However, a variety of studies focused on the risk in the hereditary non-polyposis colorectal cancer (HNPCC) not the sporadic colorectal cancer (CRC) patients. The aim of this meta-analysis was to comprehensive overview and quantitative summary the association between MSI and risk of MPCs. A comprehensive literature search in MEDLINE, EMBASE, Web of science, ScienceDirect, Weily and OVID was conducted. Up to May 2016, we identified 22 observational studies. We calculated the summary relative risk (RR) for the risk of MPCs in MSI patients compared with microsatellites stability (MSS) patients using fixed- or random-effects models. The RR of the association between mismatch-repair gene (MMR) genotype and MPCs was 2.59 (95% confidence interval [CI], 2.06 to 3.27); the RR was 2.14 (95% CI, 1.78 to 2.57) for sporadic CRC and 5.59 (95% CI, 2.69 to 11.59) for HNPCC for the MSI versus MSS category. The subgroup analyses showed different mutant gene, mutant locus, and mutant level of MMR with different influence on the patients susceptible to MPCs. In addition, MSI genotype increase the risk of MPC was not associated with an apparently specific in regard to site, timing, age and detection method. In conclusion, this meta-analysis indicates that MSI is associated with an increased risk of MPCs both in the HNPCC and sporadic CRC patients. Our findings will form the backbone of the treatment for MSI genotype may be an important valuable strategy for MPCs prevention.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
第一作者:
第一作者机构: [1]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510000, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Canc Ctr, Dept VIP Reg, 651 East Dongfeng Rd, Guangzhou 510000, Guangdong, Peoples R China;
通讯作者:
通讯机构: [1]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510000, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Canc Ctr, Dept VIP Reg, 651 East Dongfeng Rd, Guangzhou 510000, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号